Advertisement

Molecular Medicine

, Volume 17, Issue 9–10, pp 965–973 | Cite as

STATus and Context within the Mammalian Nervous System

  • Prithi Rajan
Review Article

Abstract

Effective manipulation of human disease processes may be achieved by understanding transcriptional, posttranscriptional and epigenetic events that orchestrate cellular events. The levels of activation of specific molecules, spatial distribution and concentrations of relevant networks of signaling molecules along with the receptiveness of the chromatin to these signals are some of the parameters which dictate context. Effects elicited by the transcription factor signal transducers and activator of transcription 3 (Stat3) are discussed with respect to the context within which Stat3-mediated effects are elicited within the developing and adult mammalian nervous system. Stat3 signals are pivotal to the proliferation and differentiation of neural stem cells. They also participate in neuronal regeneration and cancers of the nervous system. An analysis of the context in which Stat3 activation occurs in these processes provides a potential predictive paradigm with which novel methods for intervention may be designed.

Notes

Acknowledgments

P Rajan would like to thank R Srinivasan for helpful suggestions on the manuscript.

References

  1. 1.
    Shuai K, Schindler C, Prezioso VR, Darnell JE Jr. (1992) Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science. 258:1808–12.CrossRefPubMedGoogle Scholar
  2. 2.
    Akira S, et al. (1994) Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 77:63–71.CrossRefGoogle Scholar
  3. 3.
    Raz R, Durbin JE, Levy DE. (1994) Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J. Biol. Chem. 269:24391–5.PubMedGoogle Scholar
  4. 4.
    Dewilde S, Vercelli A, Chiarle R, Poli V. (2008) Of alphas and betas: distinct and overlapping functions of STAT3 isoforms. Front Biosci. 13:6501–14.CrossRefPubMedGoogle Scholar
  5. 5.
    Dziennis S, Alkayed NJ. (2008) Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev. Neurosci. 19:341–61.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Lim CP, Cao X. (2006) Structure, function and regulation of STAT proteins. Mol. Biosyst. 2:536–50.CrossRefPubMedGoogle Scholar
  7. 7.
    Sehgal PB. (2008) Paradigm shifts in the cell biology of STAT signaling. Semin. Cell Dev. Biol. 19:329–40.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yu H, Jove R. (2004) The STATs of cancer—new molecular targets come of age. Nat. Rev. Cancer. 4:97–105.CrossRefPubMedGoogle Scholar
  9. 9.
    Ng DC, et al. (2006) Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J. Cell Biol. 172:245–57.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Yokogami K, Wakisaka S, Avruch J, Reeves SA. (2000) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol. 10:47–50.CrossRefPubMedGoogle Scholar
  11. 11.
    Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. (1995) Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science. 267:1990–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Yuan ZL, Guan YJ, Chatterjee D, Chin YE. (2005) Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science. 307:269–73.CrossRefPubMedGoogle Scholar
  13. 13.
    Ray S, Boldogh I, Brasier AR. (2005) STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology. 129:1616–32.CrossRefPubMedGoogle Scholar
  14. 14.
    Ohbayashi N, et al. (2007) LIF- and IL-6-induced acetylation of STAT3 at Lys-685 through PI3K/Akt activation. Biol. Pharm. Bull. 30:1860–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Mowen KA, et al. (2001) Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell. 104:731–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Komyod W, Bauer UM, Heinrich PC, Haan S, Behrmann I. (2005) Are STATS arginine-methylated? J. Biol. Chem. 280:21700–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Reich NC, Liu L. (2006) Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6:602–12.CrossRefPubMedGoogle Scholar
  18. 18.
    Herrmann A, et al. (2007) Nucleocytoplasmic shuttling of persistently activated STAT3. J. Cell Sci. 120:3249–61.CrossRefPubMedGoogle Scholar
  19. 19.
    Lee KH, et al. (2008) Increased cytoplasmic levels of CIS, SOCS1, SOCS2, or SOCS3 are required for nuclear translocation. FEBS Lett. 582:2319–24.CrossRefPubMedGoogle Scholar
  20. 20.
    Pranada AL, Metz S, Herrmann A, Heinrich PC, Muller-Newen G. (2004) Real time analysis of STAT3 nucleocytoplasmic shuttling. J. Biol. Chem. 279:15114–23.CrossRefPubMedGoogle Scholar
  21. 21.
    Yang J, Stark GR. (2008) Roles of unphosphorylated STATs in signaling. Cell Res. 18:443–51.CrossRefPubMedGoogle Scholar
  22. 22.
    Ma’ayan A, et al. (2009) SNAVI: Desktop application for analysis and visualization of large-scale signaling networks. BMC Syst. Biol. 3:10.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Kidder BL, Yang J, Palmer S. (2008) Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS One. 3:e3932.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Sekkai D, et al. (2005) Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells. Stem Cells. 23:1634–42.CrossRefPubMedGoogle Scholar
  25. 25.
    Jiang K, et al. (2009) Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach. Placenta. 30:806–15.CrossRefPubMedGoogle Scholar
  26. 26.
    Korf U, et al. (2008) Quantitative protein microarrays for time-resolved measurements of protein phosphorylation. Proteomics. 8:4603–12.CrossRefPubMedGoogle Scholar
  27. 27.
    Foshay KM, Gallicano GI. (2008) Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate. Stem Cells Dev. 17:269–78.CrossRefPubMedGoogle Scholar
  28. 28.
    Androutsellis-Theotokis A, et al. (2006) Notch signalling regulates stem cell numbers in vitro and in vivo. Nature. 442:823–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Nagao M, Sugimori M, Nakafuku M. (2007) Cross talk between notch and growth factor/cytokine signaling pathways in neural stem cells. Mol. Cell. Biol. 27:3982–94.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Imamura O, Satoh Y, Endo S, Takishima K. (2008) Analysis of extracellular signal-regulated kinase 2 function in neural stem/progenitor cells via nervous system-specific gene disruption. Stem Cells. 26:3247–56.CrossRefPubMedGoogle Scholar
  31. 31.
    Bonni A, et al. (1997) Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science. 278:477–83.CrossRefPubMedGoogle Scholar
  32. 32.
    Nakashima K, et al. (1999) Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science. 284:479–82.CrossRefPubMedGoogle Scholar
  33. 33.
    Rajan P, McKay RD. (1998) Multiple routes to astrocytic differentiation in the CNS. J. Neurosci. 18:3620–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Rajan P, Panchision DM, Newell LF, McKay RD. (2003) BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J. Cell Biol. 161:911–21.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Kamakura S, et al. (2004) Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat. Cell Biol. 6:547–54.CrossRefPubMedGoogle Scholar
  36. 36.
    Gaiano N, Nye JS, Fishell G. (2000) Radial glial identity is promoted by Notch1 signaling in the murine forebrain. Neuron. 26:395–404.CrossRefPubMedGoogle Scholar
  37. 37.
    Lum M, et al. (2009) Inhibition of neurosphere proliferation by IFNgamma but not IFNbeta is coupled to neuronal differentiation. J. Neuroimmunol. 206:32–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Gu F, et al. (2005) Suppression of Stat3 promotes neurogenesis in cultured neural stem cells. J. Neurosci. Res 81:163–71.CrossRefPubMedGoogle Scholar
  39. 39.
    Sun Y, et al. (2001) Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell. 104:365–76.CrossRefPubMedGoogle Scholar
  40. 40.
    Bhattacharya S, Das AV, Mallya KB, Ahmad I. (2008) Ciliary neurotrophic factor-mediated signaling regulates neuronal versus glial differentiation of retinal stem cells/progenitors by concentration-dependent recruitment of mitogenactivated protein kinase and Janus kinase-signal transducer and activator of transcription pathways in conjunction with Notch signaling. Stem Cells. 26:2611–24.CrossRefPubMedGoogle Scholar
  41. 41.
    Kwon IS, et al. (2009) Expression of Disabled 1 suppresses astroglial differentiation in neural stem cells. Mol. Cell. Neurosci. 40:50–61.CrossRefPubMedGoogle Scholar
  42. 42.
    Molne M, et al. (2000) Early cortical precursors do not undergo LIF-mediated astrocytic differentiation. J. Neurosci. Res 59:301–11.CrossRefPubMedGoogle Scholar
  43. 43.
    Takizawa T, et al. (2001) DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev. Cell. 1:749–58.CrossRefPubMedGoogle Scholar
  44. 44.
    Song MR, Ghosh A. (2004) FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation. Nat. Neurosci. 7:229–35.CrossRefPubMedGoogle Scholar
  45. 45.
    Fan G, et al. (2005) DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling. Development. 132:3345–56.CrossRefPubMedGoogle Scholar
  46. 46.
    Namihira M, et al. (2009) Committed neuronal precursors confer astrocytic potential on residual neural precursor cells. Dev. Cell. 16:245–55.CrossRefPubMedGoogle Scholar
  47. 47.
    Kohyama J, et al. (2008) Epigenetic regulation of neural cell differentiation plasticity in the adult mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 105:18012–7.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Asano H, et al. (2009) Astrocyte differentiation of neural precursor cells is enhanced by retinoic acid through a change in epigenetic modification. Stem Cells. 27:2744–52.CrossRefPubMedGoogle Scholar
  49. 49.
    Kinoshita MO, et al. (2009) Lipid rafts enriched in phosphatidylglucoside direct astroglial differentiation by regulating tyrosine kinase activity of epidermal growth factor receptors. Biochem. J. 419:565–75.CrossRefPubMedGoogle Scholar
  50. 50.
    Miao T, et al. (2008) SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinase. Mol. Cell. Neurosci. 37:367–75.CrossRefPubMedGoogle Scholar
  51. 51.
    Qin H, Niyongere SA, Lee SJ, Baker BJ, Benveniste EN. (2008) Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J. Immunol. 181:3167–76.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Gong L, et al. (2008) Signal transducer and activator of transcription-3 is required in hypothalamic agouti-related protein/neuropeptide Y neurons for normal energy homeostasis. Endocrinology. 149:3346–54.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Benomar Y, et al. (2009) Leptin but not ciliary neurotrophic factor (CNTF) induces phosphotyrosine phosphatase-1B expression in human neuronal cells (SH-SY5Y): putative explanation of CNTF efficacy in leptin-resistant state. Endocrinology. 150:1182–91.CrossRefPubMedGoogle Scholar
  54. 54.
    Turkson J, Jove R. (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene. 19:6613–6626.CrossRefPubMedGoogle Scholar
  55. 55.
    Penuelas S, et al. (2009) TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell. 15:315–27.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Wang H, et al. (2009) Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells. 27:2393–404.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Sherry MM, Reeves A, Wu JK, Cochran BH. (2009) STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells. 27:2383–92.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Aeder SE, Martin PM, Soh JW, Hussaini IM. (2004) PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene. 23:9062–9.CrossRefPubMedGoogle Scholar
  59. 59.
    Piccirillo SG, et al. (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 444:761–5.CrossRefGoogle Scholar
  60. 60.
    Martini M, et al. (2008) Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme. Int. J. Cancer. 123:2955–60.CrossRefPubMedGoogle Scholar
  61. 61.
    Zhou H, et al. (2007) Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. Clin. Cancer Res. 13:2344–53.CrossRefPubMedGoogle Scholar
  62. 62.
    Lee J, et al. (2008) Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell. 13:69–80.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Martinez R, Esteller M. (2010) The DNA methylome of glioblastoma multiforme. Neurobiol. Dis. 39:40–6.CrossRefPubMedGoogle Scholar
  64. 64.
    Kefas B, et al. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68:3566–72.CrossRefPubMedGoogle Scholar
  65. 65.
    Li Y, et al. (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 69:7569–76.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Carro MS, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature. 463:318–25.CrossRefPubMedGoogle Scholar
  67. 67.
    Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science. 321:1807–12.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Hussain SF, et al. (2007) A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res. 67:9630–6.CrossRefPubMedGoogle Scholar
  69. 69.
    Yu H, Kortylewski M, Pardoll D. (2007) Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 7:41–51.CrossRefPubMedGoogle Scholar
  70. 70.
    Herrmann A, et al. (2010) Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells. Cancer Res. 70:7455–64.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Kortylewski M, et al. (2009) In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat. Biotechnol. 27:925–32.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Schaefer LK, Ren Z, Fuller GN, Schaefer TS. (2002) Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene. 21:2058–65.CrossRefPubMedGoogle Scholar
  73. 73.
    Morga E, et al. (2009) Jagged1 regulates the activation of astrocytes via modulation of NFkappaB and JAK/STAT/SOCS pathways. Glia. 57:1741–53.CrossRefPubMedGoogle Scholar
  74. 74.
    Beurel E, Jope RS. (2008) Differential regulation of STAT family members by glycogen synthase kinase-3. J Biol. Chem. 283:21934–44.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Baker BJ, Qin H, Benveniste EN. (2008) Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes. Glia. 56:1250–62.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Fausto N. (2000) Liver regeneration. J. Hepatol. 32:19–31.CrossRefGoogle Scholar
  77. 77.
    Rajan P, Stewart CL, Fink JS. (1995) LIF-mediated activation of STAT proteins after neuronal injury in vivo. Neuroreport. 6:2240–4.CrossRefPubMedGoogle Scholar
  78. 78.
    Rao MS, et al. (1993) Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron. 11:1175–85.CrossRefPubMedGoogle Scholar
  79. 79.
    Rajan P, Gearan T, Fink JS. (1998) Leukemia inhibitory factor and NGF regulate signal transducers and activators of transcription activation in sympathetic ganglia: convergence of cytokine-and neurotrophin-signaling pathways. Brain Res. 802:198–204.CrossRefPubMedGoogle Scholar
  80. 80.
    Shadiack AM, Vaccariello SA, Sun Y, Zigmond RE. (1998) Nerve growth factor inhibits sympathetic neurons’ response to an injury cytokine. Proc. Natl. Acad. Sci. U. S. A. 95:7727–30.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Smith RP, et al. (2010) Transcriptional profiling of intrinsic PNS factors in the postnatal mouse. Mol. Cell. Neurosci. 46:32–44.CrossRefPubMedGoogle Scholar
  82. 82.
    Kretz A, Happold CJ, Marticke JK, Isenmann S. (2005) Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol. Cell. Neurosci. 29:569–79.CrossRefPubMedGoogle Scholar
  83. 83.
    Lund IV, et al. (2008) BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway. Sci. Signal. 1:ra9.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Purow BW, et al. (2005) Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res. 65:2353–63.CrossRefPubMedGoogle Scholar
  85. 85.
    Kanamori M, et al. (2007) Contribution of Notch signaling activation to human glioblastoma multiforme. J. Neurosurg. 106:417–27.CrossRefPubMedGoogle Scholar
  86. 86.
    Wang J, et al. (2010) Notch promotes radioresistance of glioma stem cells. Stem Cells. 28:17–28.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Chen J, et al. (2010) Inhibition of Notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. Genes Cancer. 1:822–35.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Kefas B, et al. (2009) The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. J. Neurosci. 29:15161–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Feinstein Institute for Medical Research 2011
www.feinsteininstitute.org

Authors and Affiliations

  1. 1.Department of Chemical PhysiologyThe Scripps Research InstituteLa JollaUSA

Personalised recommendations